Michelle Craske, Ph.D., interviewed by Jacqueline Persons, Ph.D.
Exposure therapy has consistently been found to be a highly efficacious treatment for anxiety disorders. New research on an inhibitory learning model of extinction is leading to a re-conceptualization of the underlying theory of exposure therapy and has important implications for clinical practice. Michelle Craske, PhD is an international leader in the field of anxiety disorders and has been on the forefront of research on the inhibitory learning model. She and her colleagues recently published a paper (Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: An inhibitory learning approach. Behaviour Reseach and Therapy, 58, 10-23.) that translates many years of basic science and clinical research into practical suggestions for how to conduct exposure therapy to maximize treatment gains and reduce the likelihood of symptom relapse. In this interview, Jacqueline Persons, PhD speaks with Dr. Craske about this work and how clinicians can apply the findings from this research to their work with anxious patients.
After you listen to the interview, please complete the feedback form below.
Interview and Article
Commenting on previous topics is open to all, but you must be a member to add new comments.
Not yet an SSCP member? SSCP is one of the only organizations to align itself with both clinical research and clinical practice. Your membership not only gives you access to a rich variety of programs and benefits, but also supports the broader goal of promoting science in clinical psychology. Click here learn more about why you should join!